Slaughter retires as head of US NPRA

22 June 2007 23:20  [Source: ICIS news]

WASHINGTON (ICIS news)--Robert Slaughter is retiring as president of the National Petrochemical & Refiners Association (NPRA) after a nine-year tenure, the trade group said on Friday.

 

No reason was given for his departure, and association officials were not immediately available to comment. Late last year, the association said Slaughter was taking a leave of absence for health-related reasons.

 

NPRA chairman James Mahoney said in a statement that Slaughter’s leadership “has proven to be an outstanding asset to our industry during tumultuous times on Capitol Hill and through two administrations that have held vastly opposing views on how to develop and implement national energy policy”.

 

Mahoney, who serves as operations vice president at Koch Industries, said that as a result of Slaughter’s guidance, “NPRA and our industry are stronger than ever”.

 

“We wish him the very best in the future,” Mahoney said.

 

Slaughter was named president of the association in 2002. Previously he had served as the group’s general counsel.

 

In a statement accompanying the announcement, Slaughter expressed thanks to the association’s staff in Washington.

 

“The last nine years were not without their challenges, but it has been a truly rewarding experience facing those challenges knowing that I was representing quality businesses led by some of the most innovative minds in corporate America and staffed by the hardest working employees of any industry,” Slaughter said in a statement.

 

NPRA executive vice president Charles Drevna will head the association as the search for a new president begins, the group said.

By: Joe Kamalick
+1 713 525 2653

For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.

Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.

Printer Friendly